2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- 700.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Quick-Med Tech (QMDT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 05/13/2026
Company Profile
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The company's core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials. In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products. Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.
Key Executives
- Bernd Liesenfeld
- Gregory S. Schultz
Current Ownership Distribution
- Other30.9M (82.61%)
- Insiders6.5M (17.39%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)